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Abstract
Background: Trypanosoma cruzi is classified into six discrete taxonomic units (DTUs). For this classification, different
biological markers and classification criteria have been used. The objective was to identify the genetic profile of T. cruzi
samples isolated from patients of two municipalities of Jequitinhonha Valley, MG, Brazil.
Methods: Molecular characterization was performed using two different criteria for T. cruzi typing to characterize 63 T.
cruzi samples isolated from chronic Chagas disease patients. The characterizations followed two distinct methodologies.
Additionally, the RAPD technique was used to evaluate the existence of genetic intragroup variability.
Results: The first methodology identified 89 % of the samples as TcII, but it was not possible to define the genetic
identity of seven isolates. The results obtained with the second methodology corroborated the classification as TcII of
the same samples and defined the classification of the other seven as TcVI. RAPD analysis showed lower intra-group
variability in TcII.
Conclusions: The results confirmed the preliminary data obtained in other municipalities of the Jequitinhonha Valley,
showing a predominance of TcII, similar to that verified in northeast/south axis of Brazil and the first detection of TcVI in
the study region. The second protocol was more simple and reliable to identify samples of hybrid character.
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Background
At present approximately 6 to 7 million people are esti-
mated to be infected worldwide with Trypanosoma cruzi,
the etiologic agent of Chagas disease, mostly in Latin
America where Chagas disease is endemic [1]. T. cruzi,
is a flagellate digenetic protozoan belonging to the order
Kinetoplastida, family Trypanosomatidae [2], dispersed
throughout the American continent from Argentina and
Chile to the southern United States of America. Several
studies have demonstrated that this protozoan is heteroge-
neous, consisting of several sub-populations of parasites
that circulate in both, domestic and wild environments,
with a high rate of biological and genetic diversity [3–5].
Currently, according to the second taxonomic consensus
for T. cruzi approved during the XXV Protozoology Meet-
ing held in Buzios, RJ, Brazil, the species is subdivided into
six discrete typing units (DTU) named TcI, TcII, TcIII, TcIV,
TcV and TcVI [6], related to several previous classifications
based on different molecular markers. Regarding the geo-
graphical distribution of the T. cruzi genotypes, it has been
demonstrated that TcI has the largest distribution in all
America. In Colombia, Mexico, Guatemala, Venezuela,
Panama and Bolivia there is evidence of a predominance of
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this DTU circulating in the sylvatic [7] and domestic cy-
cles, associated in some cases to cardiac clinical forms in
humans [8–10]. In the Southern Cone countries, both
DTUs (TcI and TcII) were observed in the sylvatic cycle
[8–10]. However, only TcII was predominantly associated
with human infection, while TcI was rarely found in
humans [11, 12]. T. cruzi III was detected in human infec-
tions [8] and both, TcIII and TcIV [8, 9] are mainly en-
countered in the sylvatic and domestic cycles. TcII, TcV
and TcVI are frequently isolated from infected individuals
in the south of America but rarely isolated from sylvatic
transmission cycles [13, 14].
Although few studies have been accomplished in Brazil
concerning lesser T. cruzi subdivisions, there is evidence
that the majority of the strains isolated from patients be-
long to TcII [11, 15, 16] and less frequently to TcV; except
in the Amazon Basin where TcI is the most prevalent
DTU infecting humans while TcIII and TcIV DTUs were
occasionally recorded [17, 18]. At present in Brazil, the
TcII strains seem to be more associated with human infec-
tions responsible for tissue damage, and consequently
with several clinical forms of Chagas disease, while cases
of human infections caused by TcI strains are still rare
and usually asymptomatic [19], despite the recording
of some symptomatic cases of Chagas disease in the
Amazon with cardiac manifestations [20, 21].
Due to the scarcity of publications regarding the geo-
graphic distribution of the newly classified T. cruzi
DTUs, including in Brazil, this study proposed to
characterize genetically samples of this parasite isolated
from patients with chronic Chagas disease living in an
important endemic area of Brazil named Jequitinhonha
Valley. We aimed to highlight that the knowledge of
the distribution and intragroup variability of the newly
categorized T. cruzi genotypes in the domestic cycle of
Chagas disease in this region, where all severe clinical
forms of the disease are present, may provide additional
contributions to further investigation of the association
between the T. cruzi genotype and the pathophysio-
logical aspects of this disease, not evaluated yet, con-
tinuously researched by several authors [16, 22].
Methods
Patients and samples of T. cruzi
The samples of T. cruzi (n = 63) evaluated in this study
were isolated from patients in the early (7/63 patients with
less than 14 years old) and later chronic phases (56/63) of
Chagas disease, all born and living in the municipalities of
Berilo (62 patients) and José Gonçalves de Minas (only one
patient), distant 24 km, both of the Jequitinhonha Valley,
MG, Brazil. There were 19 male and 44 female patients,
aged between 7 and 73 years. For isolation of the parasites
the hemoculture technique [23] was used. In addition,
the reference clones of the six T. cruzi DTUs, kindly
provided by Dr. Michel Tibayrenc (IRD, France), were also
characterized in parallel: TcI (P209 cl1, 92101601P cl1 and
Cutia cl1), TcII (MAS cl1 and Tu18 clI), TcIII (CM-17 and
X-109/2), TcIV (CAnIII cl1 and 92122102R), TcV
(BUG2148 cl1 and SO3 cl5) and TcVI (P63 cl1 and Tula-
huen cl2).
Preparation of T. cruzi cell pellets
After isolation by hemoculture parasites were maintained
in growth by successive addition of LIT (Liver Infusion
Tryptose) medium up 35 ml of culture. Then, the cultures
were subjected to four cycles of washing and centrifugation,
using sterile phosphate buffered saline (PBS) at 3500 rpm,
4 °C to prepare damp mass.
Extraction of DNA
DNA extraction was processed after thawing and
homogenization of the wet mass of each T. cruzi
sample. DNA from the samples was obtained using
the WizardTM Genomic DNA Purification Kit (Pro-
mega, Madison, WI, USA), following the manufactur-
er's instructions. For molecular analysis, the DNA
samples were diluted at a concentration of 3 ng/μL.
Control DNA and reagent-free samples were proc-
essed in parallel.
Criteria for T. cruzi genotyping
The criteria [24] and [16] showed in Table 1 were used for
T. cruzi genotyping, both recommended by the expert








Westenberger et al. (2005)
RFLP-COXII
Freitas et al. (2006)
SL-IR
Burgos et al. (2007)
DNA fragments in base pairs and the number of bands expected
TcI 110 bp 1 band 2 bands Haplotype A (262 bp + 81 bp + 30 bp) ~150/157 bp
TcII 125 bp 1 band 3 bands Haplotype C (212 bp + 81 bp) ~150/157 bp
TcIII 110 bp 2 bands 2 bands Haplotype B (294 bp + 81 bp) 200 bp
TcIV ~120 bp 1 band 3 bands Haplotype B (294 bp + 81 bp) 200 bp
TcV 110 bp + 125 bp 3 bands 4 bands Haplotype B (294 bp + 81 bp) ~150/157 bp
TcVI 125 bp 3 bands 4 bands Haplotype B (294 bp + 81 bp) ~150/157 bp
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committee [4]. In the genotyping protocol [24] the samples
were subjected to a PCR algorithm for DTU genotyping
which combines the analyses of the polymorphism of the
24sα-LSU rDNA gene as well as the profile of bands ob-
tained after PCR-RFLP of the HSP60 and GPI genes. In the
protocol [16] the 24Sα-LSU rDNA miniexons and the pro-
file of bands observed after PCR-RFLP of subunit II of the
Cytochrome oxidase gene polymorphism were analyzed.
Amplification of the 3' region of the rDNA gene 24Sα-LSU
rDNA
All DNA samples were subjected to three successive PCR
amplifications of the divergent domain D7 of 24Sα subunit
rDNA (LSU rDNA) according to methodology [25] using a
thermocycler (Biocycler MJ96G). The PCR products were
subjected to electrophoresis in 6 % polyacrylamide gel and
revealed by silver staining [26].
PCR-RFLP (restriction fragment length polymorphism) of
HSP60 (heat shock protein) and GPI (glucose 6-phosphate
isomerase) genes
The polymorphism of HSP60 (heat shock protein) and
GPI (glucose 6-phosphate isomerase) genes for the popula-
tions of T. cruzi was evaluated according to the protocol
[27] using the primers HSP60-1 and HSP60-2 described in
[28] for HSP60 and the primers SO1 and SO2 described in
[29] for GPI.
PCR was performed using the thermocycler Biocycler
MJ 96G, and the digestion reaction with the restriction en-
zymes was performed using EcoRV for HSP60 and HhaI
for GPI according to the manufacturer’s instructions.
The products were subjected to electrophoresis in a
1.5 % agarose gel and revealed by staining with ethidium
bromide.
PCR of the mitochondrial gene cytochrome oxidase
subunit II
For amplification of the gene region comprising a fragment
of subunit II of the mitochondrial enzyme Cytochrome oxi-
dase (COII) the protocol [30] using TcMit10 and TcMit21
primers was used. Subsequently, 10 μL of the amplified
products were digested employing the restriction enzyme
AluI (Invitrogen, USA, 4 to 12 U/μL) according to the man-
ufacturer’s instructions. The fragments generated were vi-
sualized in 6 % polyacrylamide gel stained with silver [26].
Intergenic spacer miniexon genes of T. cruzi (SL-IR)
For amplification of the intergenic region of the miniexon
genes the protocol [31] was used employing TcIII and
UTCC primers. The analysis of the amplified products
was performed in 1.5 % agarose gel stained with ethidium
bromide.
RAPD (Random Amplified Polymorphic DNA)
RAPD analysis following the [32] methodology was used
with the objective of verifying the intra-group genetic vari-
ability using 10 different primers: A10 - 5’ GTGATCGC
AT 3’, A7 - 5’GAAACGGGTG 3’, A15 - 5’ TTCCGAACCC
3’, B15 - 5’GGAGGGTGTT 3’, B19 - 5’ACCCCCGAAG 3’,
F13 - 5’ GGCTGCAGAA 3’, F15 - 5’ CCAGTACTCC 3’,
N9 - 5’ TGCCGGCTTG 3’, N19 - 5’ GTCCGTACTG 3’,
U7 - 5’ CCTGCTCATC 3’.
The RAPD profiles were used to construct a matrix
of presence/absence of each band visualized, from
which an analysis of similarity was constructed [33]
using NTSYSpc software [34]. The relationships be-
tween T. cruzi strains were estimated using a dendro-
gram representative of the RAPD data. They were
constructed based on DICE coefficient [33] and un-
weighted pair group analysis (UPGMA) using the Mega
6.04 Beta software. In order to estimate Shannon diver-
sity, cophenetic correlation coefficient, heterozygosity
per locus (He) and principle coordinates analysis
(PCoA) were performed using GenAlEx 6.5 software. In
this case, a genetic distance matrix was constructed.
This calculation of pairwise genetic distances for binary
data followed the method [35], in which any compari-
son with the same state yields a value of 0 (both 0 vs. 0
comparisons and 1 vs. 1 comparisons), while any com-
parison of different states (0 vs. 1 or 1 vs. 0) yields a
value of 1.
Ethics
The isolation of the T. cruzi samples here characterized
was obtained of the patients by blood collection performed
after obtaining of a signed consent form approved by the
Ethics Committee for Research in Humans from the
Centro de Pesquisas René Rachou (CPqRR), FIOCRUZ,
Belo Horizonte, MG (Process Number 007/02).
Results
Genotyping according to the methodologies 24Sα rDNA,
PCR-RFLP HSP60 and GPI genes [24]
According to the criterion [24] 56 out of 63 isolates
showed band profiles compatible with TcII DTU: 125 bp
(rDNA type I) for 24Sα rDNA gene products (Fig. 1); a
single band for PCR-RFLP HSP60/EcoRV (Fig. 1 and
Table 2) and three bands for PCR-RFLP GPI/HhaI (Fig. 1
and Table 2) compatible with the reference clone of the
TcII DTU (MAScl1). However, with seven isolates it was
not possible to reach a consensus following this method-
ology. Although these seven samples gave the 125 bp
fragment for analysis of the polymorphism of D7 24Sα
rDNA (LSUrDNA), for the other markers there was no
correlation with the expected band profiles. Samples
229, 748, 798, 1205, 1337, 2118 and 2119 showed pro-
files of triple bands for PCR-RFLP of the HSP60 gene
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(triple fragments ranging from 100 to 432 bp) character-
istic of hybrid lineages or TcV or TcVI (Fig. 1 and
Table 2), and double bands, characteristic of the lineages
TcI and TcIII for PCR-RFLP of the GPI gene (Fig. 1 and
Table 2).
Genotyping according to the methodologies 24Sα rDNA,
PCR-RFLP COII gene and Miniexon SL-IR [16]
Due to results obtained above all samples were also ana-
lyzed by the protocol proposed by [16]. The fifty-six sam-
ples previously identified as TcII by the protocol [24] had
Fig. 1 a - Profiles obtained by DNA genotyping of Trypanosoma cruzi samples isolated from patients of the Jequitinhonha Valley, Minas Gerais,
Brazil, resultant from the amplification of the 3' region of the 24Sα rDNA gene. MW - Molecular weight of 100 bp, Br - negative reaction control,
TcI - representative clone of TcI lineage (P209 cl1, 110 bp), TcIV - representative clone TcIV lineage (CANIII, 120 bp), TcII - representative clone of
TcII lineage (MAS cl1, 125 bp), TcIII - representative clone of the TcIII lineage (CM-17, 110 bp), TcVI - representative clone of the hybrid lineage
TcVI (Tulahuen cl2, 125 bp) and TcV - representative clone of TcV lineage (Bug2148, 110 bp + 125 bp). A1 – sample 229, A2 – sample 452, A3 – sample
748, A4 - sample 798, A5 –sample 205, A6 – sample 1918, A7 –sample 2535, A8 –sample 2491, A9 –sample 264, A10 – sample 376, A11 – sample 646
and A12 – sample 211. b - Profiles obtained with DNA of Trypanosoma cruzi samples isolated from chagasic patients of the Jequitinhonha Valley, Minas
Gerais, Brazil, by the analysis of the HSP60 gene polymorphism after PCR-RFLP. MW - Molecular weight of 100 bp, A1 – sample 1918, A2 – sample
PSF060, A3 – sample 438, A4 – sample 543, A5 – sample 229, A6 – sample 2119. Br – PCR negative control; TcI – TcVI samples profile of
the reference clones of the 6 lineages of T. cruzi (TcI - P209 cl1, single band of 432 – 462 bp; TcII – MAS cl1, single band of 432 – 462 bp; TcIII – CM-17
double bands; TcIV – CAN III cl1, single band; TcV – Bug 2148, triple bands; TcVI – Tulahuen cl2, triple bands). c - Profiles of DNA genotyping of T. cruzi
samples isolated from chagasic patients of the Jequitinhonha Valley, Minas Gerais, Brazil, by the analysis of GPI/HhaI gene polymorphism via PCR-RFLP.
MW - Molecular weight of 100 bp, BR – PCR negative control, A1 – sample 2014, A2 – sample 646, A3 – sample 453, A4 – sample 2119, A5 – sample 440,
A6 – sample 501, A7 – sample 523, A8 – sample 2478, A9 – sample PSF060, A10 – sample 1100, A11 – sample 820, and A12– sample 2535.TcII – (clone
TU18 cl1 representative of DTU TcII), TcV – (clone SO3 cl5, DTU TcV), TcI – (clone 92101601P cl1, DTU TcI), TcIII – (Clone X109/2, DTU TcIII), TcVI – (clone
Tulahuen, DTU TcVI) and TcIV – (CANIII cl1 DTU TcIV)




DTU TcII DTU TcVI
Lewis et al., (2009) PSF060, 103, 264, 299, 376, 438, 440, 452, 467, 479, 493, 501, 523, 525, 529, 543, 595, 646, 653, 701,
728, 791, 795, 806, 817, 818, 820, 829, 839, 845, 855, 860, 896, 914, 953, 1100, 1107,1113, 1315, 1442,
1536, 1661, 1662, 1663 1635, 1918, 2014,2336,2337, 2339, 2405, 2408, 2478, 2491, 2495, 2497
?????
D’Ávilla et al., (2009) PSF060, 103, 264, 299, 376, 438, 440, 452, 467, 479, 493, 501, 523, 525, 529, 543, 595, 646, 653, 701,
728, 791, 795, 806, 817, 818, 820, 829, 839, 845, 855, 860, 896, 914, 953, 1100, 1107, 1113, 1315, 1442,
1536, 1661, 1662, 1663 1635, 1918, 2014, 2336, 2337, 2339, 2405, 2408, 2478, 2491, 2495, 2497
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the typing confirmed: 125 bp (rDNA type I) for amplified
products of 24Sα rDNA; 212 bp + 81 bp, characteristic of
mitochondrial haplotype C lineage and 150 bp −157 bp
for amplified products of intergenic spacer of the mini-
exon (SL-IR) of T. cruzi, typical of TcII MAScl1 reference
clone. The seven samples with previous controversial
identification (229, 748, 798, 1205, 1337, 2118, 2119)
showed a double profile of bands of 294 bp and 81 bp
(Fig. 2 and Table 2) for PCR-RFLP COII, similar to the ref-
erence clones of the haplotype B (CM-17 and Tulahuen
cl2) or strains belonging to TcIII, TcIV and TcVI lineages.
Regarding the amplification of the DNA fragment of the
intergenic miniexon spacer (SL-IR) of T. cruzi, all samples
showed band profiles of approximately 150–157 bp, char-
acteristic of the TcI, TcII, TcV and TcVI lineages [31] (Fig. 2
and Table 2).
Therefore, according to the protocol [16] it was verified
that the seven samples with inconclusive results in the
protocol proposed by [24] were all classified as belonging
to DTUTcVI because they presented a profile of 125 bp
fragment for the rDNA gene, approximately 150–157 bp
fragment for the intergenic spacer of the miniexon and
294 bp and 81 bp (mitochondrial haplogroup B) which
allowed the classification of the T. cruzi samples as
belonging to TcVI compatible with the Taluhen cl2 refer-
ence clone (Table 1) of this T. cruzi DTU.
RAPD analysis
For RAPD analysis only bands showing sharp fragments
were selected. After amplification 4731 fragments were
detected in the two different DTUs. The size of bands
ranged between 100 and 1400 bp.
The RAPD profiles were complex, with a total of 81
bands of which only 12 (14.8 %) were shared among all the
samples. The proportion of polymorphic loci was 72.84 %.
The cophenetic correlation coefficient that checks that a
Fig. 2 a – Profiles obtained by DNA genotyping of Trypanosoma cruzi isolated from patients of the Jequitinhonha Valley, Minas Gerais, Brazil, of
the region 3' of the 24Sα rDNA gene. MW - Molecular weight of 100 bp, Br – PCR negative control. TcI – TcI representative clone (P209 cl1 profile
of 110 bp), TcIV – representative clone of TcIV (CANIII, 120 bp), TcII - representative clone of TcII(MAS cl1, 125 bp), TcIII – representative clone of
the lineage TcIII (CM-17, 110 bp), TcVI – representative of the hybrid lineage TcVI (Tulahuen cl2, 125 bp) and TcV – representative clone of lineage
TcV (Bug2148, 110 bp + 125 bp); A1 – sample 229, A2 – sample 452, A3 – sample 748, A4 – sample 798, A5 – sample 1205, A6 – sample 1918, A7 –
sample 2535, A8 –sample 2491, A9 – sample 264, A10 – sample 376, A11 – sample 646 and A12 – sample 2118. b - Profiles obtained by DNA genotyping
of Trypanosoma cruzi isolated from patients of the Jequitinhonha Valley, Minas Gerais, Brazil, by analysis of polymorphism of subunit II of the cytochrome
oxidase gene (COII). MW - Molecular weight of 1 kb, BR – PCR negative control, TcI – profile of bands of clone P209 cl1 (mitochondrial haplotype A - DTU
TcI, Freitas et al., 2006), TcII – Tu18 cl2 (haplotype C - DTU TcII), TcVI –M6241 CL6 and C4 – Tulahuen cl2 (mitochondrial haplotype B - DTU TcIII and DTU
TcVI); A1 – sample 452, A2 – sample 2535, A3 – sample 376, A4 – sample 229, A5 – 2408 sample, A6 – sample 264, A7 – sample 748, A8 – 1918 sample,
A9 – sample 2491, A10 – sample 798, A11 – sample 501, A12 – sample 2118. c- Profiles obtained by DNA genotyping of Trypanosoma cruzi isolated from
patients of the Jequitinhonha Valley, Minas Gerais, Brazil, by analysis of polymorphism of the intergenic spacer of the miniexon. MW - Molecular weight
standard 1 kb; C1 – clone Agouti cl1 (DTU TcI), C2 – clone Tu18cl1 (DTU TcII), C3 and C4 – clones X109 2 (DTU TcIII) and 9212210R2 (DTU TcIV), C5 and
C6 – clones SO3cl5 and Tula cl2 representatives of DTU (s) TcV and TcVI, respectively; A1 – sample 229, A2 – sample 452, A3 – sample 748, A4 – sample
798, A5 – sample 1205, A6 – sample 1337, A7 – sample 2118, A8 – sample 2119; A9 – sample 376, A10 – sample 2491, A11 – sample 493; A12 – sample
820, A13 – sample 1107; A14 – sample 2478; A15 – sample 1918; A16 – sample 2014, Br: PCR negative control
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dendrogram faithfully preserves the pairwise distances
between the original unmodeled data points gave a coeffi-
cient value of 0.989, confirming good representation of the
similarity matrices in the form of the dendrogram. The
UPGMA dendrogram distinguished the samples into three
distinct clusters (Fig. 3). PCoA for the first two axes con-
solidated 82.27 % of the variation between the components
(Fig. 4) and the total formed three groups, as shown in the
UPGMA dendrogram. The expected mean heterozygosity
per locus (He) was 0.181, indicative of low genetic diversity
among samples. Moreover, the Shannon diversity index
(0.284), which is a quantitative measure that reflects how
many different types there are in a dataset was also consid-
ered low. This evaluation has been used to describe the
species richness. When this index is closer to 1.0, greater is
the species diversity.
Fig. 3 UPGMA (Unweighted Pair-Group Method Analysis) phenogram of all 63 isolates of Trypanosoma cruzi. The numbers on the horizontal scale
were obtained from the Dice similarity coefficient
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Discussion
T. cruzi, the etiologic agent of Chagas disease, is com-
posed of heterogeneous subpopulations circulating in both
sylvatic and domestic cycles [36], and this diversity can be
detected at morphological [37], biological [3], antigenic
[38], epidemiological [4] and genetic levels [36, 39].
Therefore, to better understand the disease it is import-
ant to study the molecular epidemiology of this parasite,
which naturally is related with the characteristics men-
tioned. So, the present study was developed with the pur-
pose of identification of the genetic lineages of T. cruzi
samples isolated from chronic chagasic patients of the
Jequitinhonha Valley, MG, considered an area of intense
transmission of Chagas disease in the 1980s [40] and (ii)
to evaluate the molecular descriptive epidemiology of T.
cruzi within this population.
For molecular typing it was firstly used the protocol
proposed by [24]. Considering the 63 samples evaluated,
a total of 56 T. cruzi samples showed a profile consistent
with TcII as previously demonstrated in patients of
Virgem da Lapa municipality, located only 28 km from
Berilo and 48 km from José Gonçalves de Minas, where
the isolates were analyzed by isoenzyme profiles [41].
The first work that used the criteria proposed by [24] for
T. cruzi genotyping was the study [42] as mentioned by
[4]. They identified 18 isolates from domestic cats and
vectors in an endemic region of Chagas disease in Bahia,
all belonging to the TcII group. Our results corroborate
the obtained in this study, indicating that this method is
efficient in identifying TcII DTU. However, seven sam-
ples (229, 748, 798, 1205, 1337, 2118 and 2119) revealed
different patterns or combinations of bands to those
expected for any DTU. The results obtained by protocol
[24] already indicated genetic variation in the profiles of
some clones used as reference in their work. The clone
Saimiri3 cl1, for example, showed a profile of TcIV in
RAPD analysis. However, the triple assay showed incon-
clusive identification closer to the profile of TcII than
any other genetic group. The most important issue that
may hinder the identification of the isolates is the occur-
rence of mixed infections or multiconality already docu-
mented in vectors, several reservoirs and human [38],
but fortunately not identified in our samples since the
profiles of bands detected where exactly the same veri-
fied in clones of reference for each T. cruzi DTU and be-
cause the pattern of bands for each one is intra-DTU
excludent [6]. Additionally, when a mixture of TcIII and
TcII clones occurred in [43] these authors found similar
profiles to TcV and TcVI, which could result in errone-
ous identification or characterization of the isolates,
since the samples studied by them were not cloned pre-
viously to clarify this problem.
Herein, the results showed that more genetic variabil-
ity may be observed when more samples from distinct
Fig. 4 Principal coordinated analysis (PCoA) for the different strains of Trypanosoma cruzi
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geographic areas are typed using this protocol. For our
seven samples that showed different patterns of bands
for the expected by the protocol [24] a process may be
occurring, such as nucleotides deletion or insertion of
the GPI gene sequence, which prevented the enzyme to
cut the DNA sequence at the specific site. On the other
hand, [44, 45] publications do not have problems with
the use of GPI gene as a marker, however employing dif-
ferent protocols. The isoenzyme analysis of these isolates
for GPI also showed a profile of bands distinct from that
expected for the TcVI stocks (data not shown). Our ana-
lysis of GPI showed profiles corresponding to those
expected for TcIV and TcIII DTUs, which could suggest
a more extensive variation in the gene, but for others
(G6PD and IDH) the profile was compatible with TcVI
(data not shown). Regarding the use of the HSP60 gene
as a marker, there are not many publications that deal
with this methodology, except the works [27] and [28].
In this study we did not observe differences between the
representative samples of the same lineage for these two
genes using the PCR-RFLP. However, it is important to
note those authors used clones of references previously
genotyped by others markers, as well as different restric-
tion enzymes to cut the HSP60 and GPI gene fragments,
which could explain the absence of differences observed
compared to the present study that genotyped new sam-
ples isolated from humans.
To solve the typing of these seven samples the protocol
provided by [16] was also employed in the characterization
of all samples. According to [31] when incongruity occurs
in the identification of T. cruzi isolates, with probable pres-
ence of a hybrid profile, the use of PCR-RFLP of the COII
gene described by [30] is important for the characterization
of the isolate to guarantee the right profile identification
because after cutting the PCR products with the AluI
enzyme, samples associated with the mitochondrial hap-
logroup B profile can be considered as belonging to the
DTUs TcIII, TcIV, TcV or TcVI. However, employing this
methodology combined with the evaluation of the poly-
morphism of the 3' rDNA gene region and of the inter-
genic region of the miniexon gene of T. cruzi (SL-IR) also
suggested a quick, cheap and effective solution for identify-
ing strains of T. cruzi as suggested by [6] and [4]. Here,
seven isolates from chronic chagasic patients (229, 748,
798, 1205, 1337, 2118 and 2119) after COII/Alu RFLP
showed profiles of representative clones of mitochondrial
haplotype B (294 bp + 81 bp) and that the DTU observed
may correspond to hybrids DTUs V and VI. The SL-IR
identified the group with a band of 200 bp, characteristic
of the lineages TcIII and TcIV. Thus, all samples analyzed
in this study amplified by this methodology showed a frag-
ment of approximately 150–157 bp, excluding the possibil-
ity of the isolates being identified as TcIII or TcIV, which
confirms that these samples are actually hybrids belonging
to DTU TcVI, due also to the results obtained in the rDNA
analysis. The other 56 samples were confirmed as TcII
genotype, including the only sample of José Gonçalves de
Minas, which corroborated the classification of [24].
Thus, the results of this study are in agreement with
several publications that claim that TcII strains are more
associated with human infection with geographical dis-
tribution between the North and mainly in the South of
Brazil [12, 15, 16, 46, 47]. In a recent review encompass-
ing the ecoepidemiology of different DTUs of T. cruzi,[4]
reaffirm this distribution and that this DTU was de-
tected both in the domestic and sylvatic cycles of Chagas
disease [48, 49] and appears to be closely related to the
cardiac and digestive clinical manifestations (megacolon
and megaesophagus) in human infection [12, 16, 30]
Predominance of 91.7 % of TcII in Brazil was demon-
strated in human cases in the state of Rio Grande do
Norte [50] similar to that observed in the Jequitinhonha
Valley, MG. These authors also verified presence of TcII
in domestic reservoirs. On the other hand, the presence
of hybrid groups represented by the DTUs TcV and TcVI
is usually associated with vectors and humans in the do-
mestic cycle of infection and rarely recorded in the syl-
vatic cycle in various geographical regions of Latin
America [51, 52]. Frequently, TcVI presents low preva-
lence in the invertebrate host than in human cases and
some mammal reservoirs [10, 52–54]. Several publica-
tions have also cited TcVI as an important lineage in-
volved in human infections in the Chaco region and
neighboring countries such as Bolivia, Chile, northern
Argentina and southern Brazil [55–57]. The existence of
TcVI in humans in Brazil was recently confirmed by [58]
when they characterized 11 strains isolated from patients
involved with oral transmission of T. cruzi in the state of
Santa Catarina. More recently, the study [8] in Colombia
demonstrated the presence and association of TcI, TcII,
TcIII and TcIV DTUs, mainly TcI and not TcII as gener-
ally demonstrated by different authors in distinct regions
such as Venezuela and Bolivia [7, 9, 10, 15, 30, 46]. To
evaluate the variability within these genetic groups RAPD
analysis was used on all samples here characterized. This
analysis clearly demonstrated the subdivision of this spe-
cies into two genetic lineages and corroborated the results
obtained by the genotyping of all isolates, grouping them
equally with the reference clones of the DTUs II and VI as
previously demonstrated. In addition, a great similarity
between the profiles of bands presented by the samples of
the same lineage was observed using the different primers,
showing only discrete variability among them. The studies
[5, 59] showed a tendency for decreasing genetic variabil-
ity of the isolates when comparing parasites isolated from
patients in the acute phase with patients in the chronic
phase of the infection using RAPD and microsatellite
methodologies. These results are consistent with the idea
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that clones of T. cruzi are able to establish stronger infec-
tions in certain hosts and such host-parasite relationships
could work as filters for some sub-populations of the para-
site [5, 49, 60]. Maybe the prolonged infection in these
patients may have provided a selection of the parasites
better adapted to the Berilo population or the ecoepide-
miological conditions of the study area. This hypothesis
justifies the similarity between the isolates grouped in a
particular branch of the phenogram.
Phenomena of T. cruzi hybridization and ecogeographi-
cal distribution of the parasite were also described by
other authors referent to TcI in Bolivia, employing loci
variability by microsatelites and mitochondrial DNA [7]
and between TcI with TcIII and TcIV, respectively [61]
using MLST and SNP as molecular markers. However, the
study of parasites isolated from reservoirs and vectors of
the same region would be necessary to better understand
the eco-epidemiology of T. cruzi in the region studied.
Conclusions
The results obtained in this study agree with data in the lit-
erature and demonstrate the predominance of the lineage
TcII in human Chagas disease in more one endemic region
of Brazil, as well as its association with genotype TcVI, now
firstly described in human infection in the Jequitinhonha
Valley, MG, Brazil, which may have been masked in the pi-
oneer classification here used due to the limitations of the
markers used which probably erroneously identified those
samples as possibly TcII.
The RAPD analysis showed low variability of the genetic
profiles between T. cruzi samples of the same lineage.
The results still suggest variation among samples from
different geographic regions, and more, that the correct
identification of T. cruzi DTUs should be made with cau-
tion and based on a larger number of markers, mainly
when hybrid samples are present.
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